544,942 Shares in Integer Holdings Corporation $ITGR Purchased by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company acquired a new position in Integer Holdings Corporation (NYSE:ITGR) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 544,942 shares of the medical equipment provider’s stock, valued at approximately $50,925,000.

Several other large investors have also bought and sold shares of ITGR. Heartland Advisors Inc. lifted its position in Integer by 506.8% during the fourth quarter. Heartland Advisors Inc. now owns 242,715 shares of the medical equipment provider’s stock valued at $19,036,000 after buying an additional 202,715 shares during the period. WINTON GROUP Ltd purchased a new stake in shares of Integer in the 4th quarter worth about $4,836,000. Jennison Associates LLC purchased a new stake in shares of Integer in the 4th quarter worth about $1,036,000. Kestrel Investment Management Corp bought a new position in shares of Integer in the 4th quarter worth about $5,933,000. Finally, William Blair Investment Management LLC increased its stake in shares of Integer by 70.1% in the 4th quarter. William Blair Investment Management LLC now owns 468,377 shares of the medical equipment provider’s stock worth $36,735,000 after acquiring an additional 192,956 shares in the last quarter. 99.29% of the stock is owned by institutional investors.

Integer Trading Down 0.1%

NYSE:ITGR opened at $125.32 on Thursday. The company’s 50 day moving average price is $106.20 and its 200-day moving average price is $93.99. Integer Holdings Corporation has a 52 week low of $62.00 and a 52 week high of $126.14. The company has a quick ratio of 2.41, a current ratio of 3.73 and a debt-to-equity ratio of 0.75. The stock has a market cap of $4.26 billion, a price-to-earnings ratio of 34.24, a PEG ratio of 2.96 and a beta of 0.61.

Integer (NYSE:ITGR) last posted its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.38 by $0.22. The business had revenue of $464.11 million during the quarter, compared to analyst estimates of $451.07 million. Integer had a return on equity of 12.79% and a net margin of 6.97%.The company’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same quarter last year, the company earned $1.55 EPS. On average, equities research analysts forecast that Integer Holdings Corporation will post 6.09 earnings per share for the current fiscal year.

Integer News Summary

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Zacks raised its FY2026 EPS forecast to $6.13 from $6.05 and increased its estimates for Q2 2027 and Q1 2028 to $1.61 and $1.71, respectively. These upward revisions provide some support for the outlook.
• Neutral Sentiment: Zacks maintained a “Hold” rating on Integer. Its current full-year consensus EPS estimate is approximately $6.08, while the firm projects FY2027 EPS of $6.56 and FY2028 EPS of $6.85, indicating continued earnings growth but limited near-term conviction.
• Negative Sentiment: Zacks reduced estimates for Q3 2026 EPS to $1.63 from $1.68, Q4 2026 EPS to $1.70 from $1.77, Q1 2027 EPS to $1.46 from $1.50, Q3 2027 EPS to $1.72 from $1.87, Q4 2027 EPS to $1.77 from $1.90, FY2027 EPS to $6.56 from $6.87, and FY2028 EPS to $6.85 from $7.20. The broad reductions, particularly to full-year 2027 and 2028 forecasts, are likely the main reason the stock has weakened.

Analysts Set New Price Targets

A number of brokerages recently issued reports on ITGR. Piper Sandler cut shares of Integer from an “overweight” rating to a “hold” rating and set a $127.00 price target for the company. in a research report on Monday, August 3rd. Weiss Ratings restated a “hold (c)” rating on shares of Integer in a report on Thursday, June 18th. KeyCorp downgraded shares of Integer from an “overweight” rating to a “sector weight” rating in a research note on Monday, August 3rd. Raymond James Financial lowered shares of Integer from a “moderate buy” rating to a “hold” rating in a report on Monday, August 3rd. Finally, Oppenheimer cut Integer from an “outperform” rating to a “market perform” rating in a research report on Monday, August 3rd. One research analyst has rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $109.86.

Integer Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.